Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT03208556 · UNKNOWN
Trial details
- NCT number
- NCT03208556
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2019-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.